Related Experiment Video
Updated: Mar 11, 2026
06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.9K
Multifocal Congenital Hemangiopericytoma
Renata Robl1, Vânia Oliveira Carvalho1,2, Kerstin Taniguchi Abagge3
1Dermatologia Pediatrica, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Pediatric Dermatology
|November 23, 2016
Summary
Congenital hemangiopericytoma (HPC) is a rare tumor in newborns. This case report details a multifocal congenital HPC with severe deformity, successfully treated with chemotherapy and surgery.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Developmental Biology
Background:
- Congenital hemangiopericytoma (HPC) is a rare mesenchymal tumor in infants, generally exhibiting less aggressive behavior than adult counterparts.
- Multifocal congenital HPC is exceptionally rare, posing diagnostic challenges due to its uncommon presentation and potential for severe deformity.
Observation:
- A newborn infant presented with multifocal congenital hemangiopericytoma.
- The tumor caused significant congenital deformity.
- Despite the severity, the infant's condition was closely monitored.
Findings:
- Histologic confirmation of multifocal congenital hemangiopericytoma was established.
- The infant received a treatment regimen combining chemotherapy and surgical excision.
- A favorable clinical outcome was achieved post-treatment.
Implications:
- This case highlights the importance of recognizing multifocal congenital HPC in neonates.
- It demonstrates the efficacy of combined chemotherapy and surgical intervention for this rare condition.
- The favorable prognosis underscores the potential for successful management even with severe presentations.
